Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.
Saga, T, Neumann, R D, Heya, T, Sato, J, Kinuya, S, Le, N, ...
Monoclonal antibodies penetrate bulky tumors poorly after intravenous administration, in part because of specific binding to the target antigen. Experiments presented here demonstrate an analogous...
Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.
Saga, T, Neumann, R D, Heya, T, Sato, J, Kinuya, S, Le, N, ...
Monoclonal antibodies penetrate bulky tumors poorly after intravenous administration, in part because of specific binding to the target antigen. Experiments presented here demonstrate an analogous...